PORTLAND, Ore., Sep. 13, 2018 – Paragon BioTeck, a privately held pharmaceutical and medical device company specializing in the development and commercialization […]
“A Night to Remember” celebrates the holidays with children, families of Eugene Pearl Buck Preschool & Family Supports Program PORTLAND, […]
The Koch Kellan Scholarship honors a graduate medical student pursuing a career in ophthalmology PORTLAND, Ore. – October 2, 2017 – […]
Every visit with a patient is an opportunity to teach them about the different aspects of eye health. By encouraging regular eye examinations, I can reinforce basic wellness tips to help keep my patients’ eyes healthy and reduce the possibility of vision loss.
2017 Koch Kellan Scholar, Xinxin Zhang, was formally presented with her scholarship award at a ceremony held on Sunday, May 7. Ms. Zhang was invited to attend the 2017 ASCRS•ASOS annual meeting in Los Angeles on behalf of Paragon BioTeck where she had the opportunity to explore the conference and meet ophthalmic industry leaders. Read on to hear her thoughts about the conference and ceremony.
Each year, Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to a third-year ophthalmology student. The scholarship, named for two pillars of the eye care industry — Paul Koch, MD, and Robert Kellan, MD — highlights rising stars who share our dedication to underserved medical needs. This year, we are proud to introduce our 2017 Koch Kellan Scholar: Xinxin Zhang. We caught up with her after the announcement to learn more about her exciting work and future plans.
PORTLAND, Ore., – Paragon BioTeck, Inc., an ophthalmic pharmaceutical and device company, announced today that Xinxin Zhang has been named its 2017 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.
Age-related macular degeneration (AMD) is a leading cause of severe vision loss and legal blindness in adults over 60 in the U.S. It affects 14-24% of the U.S. population aged 65-74 and 35-40% of people 75 and older3. Though AMD alone almost never causes total blindness, as peripheral vision is not necessarily affected, the loss of any amount of vision can have a huge impact on your life. As the population ages, it is estimated that the number of Americans with AMD will grow from approximately 2 to 5 million between 2010 and 20501.
One month into 2017 and the eye care industry has hit the ground running. Here are just a few articles that caught our eye this month.
Guest Blog by Katherine Mastrota, MS, OD, FAAO, Dipl ABO
Glaucoma affects nearly 3 million Americans and more than 60 million people around the world1. As one of the leading causes of blindness, with no known cure and few early symptoms, awareness of glaucoma may be the best first step towards preventing the disease.